Byrna (NASDAQ:BYRN) Misses Q2 CY2026 Sales Expectations, Stock Drops 24.1%

Byrna (NASDAQ:BYRN) reported Q2 CY2026 revenue of $16.39 million, down 42.5% year on year, missing Wall Street expectations. GAAP EPS was -$0.44, also below consensus. Management said results did not match expected performance. The stock fell about 24% to $4.49 after the release.

Original reporting
Published Jul 9, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Byrna (NASDAQ:BYRN) Misses Q2 CY2026 Sales Expectations, Stock Drops 24.1% — source image
Decision brief

The 30-second read

$BYRNBearishMed
01

Why it matters

The key new information is the Q2 CY2026 revenue and EPS miss versus Wall Street expectations, alongside a large year-on-year revenue contraction and a sharp immediate stock drop.

02

Market read

Traders can reassess near-term growth and profitability expectations after the earnings miss and the magnitude of the stock reaction.

03

What to watch

The text highlights operating margin deterioration this quarter (-78.4%) but does not break out one-time items, channel inventory effects, or order timing that could distort the quarter.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session reaction to Q2 CY2026 results and guidance expectations

Background

Byrna is a non-lethal weapons company; the article frames its recent performance versus longer-term growth trends.

Company-level read

Ticker impact

$BYRNBearishHigh confidence
Context

Byrna reported Q2 CY2026 revenue down 42.5% to $16.39M and EPS of -$0.44, missing consensus and sending shares down ~24%.

Expected impact

Bearish bias for the next days to weeks as traders reprice growth and margin trajectory after the miss.

Evidence & confidence

The article provides specific Q2 revenue and EPS figures versus expectations, plus the immediate post-results stock drop, indicating a fresh repricing event.

Market effects

Weak demand signals for non-lethal weapons suppliers could weigh on sentiment for similarly positioned defense-adjacent small caps.

No specific regional spillover described beyond US small-cap sentiment.

No global macro or international demand drivers cited.

Counterpoint

Despite the revenue decline, the article notes EBITDA beat and operating leverage improvements, which could support a stabilization trade if margins hold.

Key entities

  • Byrna

    Reported Q2 CY2026 revenue of $16.39M (down 42.5% YoY) and EPS of -$0.44, missing expectations.

  • Conn Davis

    CEO who said Q2 results did not reflect the performance level management believes Byrna can deliver.

Related articles

$BYRNMedAI 8/10

Byrna Technologies Inc. (BYRN): Completion of Acquisition or Disposition of Assets

Byrna Technologies Inc. (BYRN) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 2.01. Completion of Acquisition or Disposition of Assets. On August 6, 2026 (the “Closing Date”), Byrna Technologies Inc. (the “Company”) completed its previously announced acquisition (the “Acquisition”) of substantially all of the assets of Hero Defense Systems, LLC, a Nev

$BYRNLow

Why Byrna (BYRN) Shares Are Sliding Today

Byrna (NASDAQ: BYRN) shares fell about 4% after the company appointed James White as Senior VP of Retail and Channel Growth, overseeing retail and e-commerce channels and reporting to CEO Conn Davis. The move follows a sales and marketing realignment. The stock traded near its 52-week low around $3.29, after prior Q2 2026 results missed expectations.

$BYRNMedAI 9/10

Byrna Technologies Q2 Earnings Call Highlights

Byrna Technologies (NASDAQ: BYRN) reported Q2 gross profit of $1.8M (11% of net revenue) versus $17.6M (62%) a year earlier, including $3.6M inventory write-down, $3.5M equipment impairment, and $2.3M inventory reserve. Net loss was $10.1M. Management cited weaker e-commerce conversion and expects no FY2026 revenue growth. Byrna agreed to acquire HERO Defense Systems for $1.25M plus royalties.

$BYRNMedAI 8/10

Why Byrna (BYRN) Stock Is Falling Today

Byrna (NASDAQ: BYRN) shares fell 25.8% after the company reported Q2 2026 results that missed expectations. Revenue dropped 42.5% year over year to $16.39 million versus $22.22 million estimates. Byrna posted a GAAP loss of $0.44 per share versus a $0.11 loss consensus and a $0.10 profit a year earlier.

$BYRNMed

Byrna Technologies Inc. (BYRN): Results of Operations and Financial Condition

Byrna Technologies Inc. (BYRN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_985847.htm EXHIBIT 99.1 ex_985847.htm Exhibit 99.1 Byrna Technologies Reports Fiscal Second Quarter 2026 Results ANDOVER, Mass., July 9, 2026 - Byrna Technologies Inc. ( “ Byrna ” or the “ Company ” ) (Nasdaq: BYRN) , a personal defense technology company specializin